Press release article from our research archive:

Millennium and Bayer Form World's Largest Drug Discovery Alliance In the Pharmaceutical Industry.

- Revolutionary Approach in Pharmaceuticals Research -

- A Production Line for Genomics-Based Drugs -

CAMBRIDGE, Mass., Sept. 23 /PRNewswire/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) and Bayer AG today announced the formation of an alliance, believed to be the largest to date, in the field of pharmaceutical drug discovery. In return for a total investment of up to $465 million, including approximately a 14 equity investment in Millennium, Bayer will receive access to key technologies in modern genome research and a flow of new genomics-based targets for drug development over a five-year period.

Together, Millennium and Bayer will pursue a new ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!